Glucagon-like Peptide-2 Acts Partially Through Central GLP-2R and MC4R in Mobilizing Stored Lipids from the Intestine
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(9), P. 1416 - 1416
Published: April 23, 2025
Background:
Glucagon-like
peptide-2
(GLP-2)
is
a
gut
hormone
secreted
in
response
to
nutrient
intake
and
regulates
lipid
metabolism
the
gut.
The
present
study
aims
elucidate
underlying
mechanism
of
GLP-2
stimulating
secretion
fasted
state
by
testing
whether
signals
through
brain’s
receptor
melanocortin
4
(MC4R).
Methods:
Sprague-Dawley
rats
were
implanted
with
mesenteric
lymph
duct
cannula
for
measuring
an
intracerebroventricular
infusion
GLP-2R
antagonist
(GLP-2(11-33)),
MC4R
(SHU9119),
or
saline
as
control.
rat
received
into
small
intestine
peritoneal
injection
five
hours
later.
Results:
Brain
administration
attenuated
stimulatory
effects
peripheral
on
triglyceride
output.
These
associated
differential
changes
expression
key
genes
jejunal
endothelial
cells,
smooth
muscle
neuronal
cells.
Conclusions:
results
support
involvement
central
neural
pathway
mobilize
lipids
stored
during
post-absorptive
state.
Language: Английский
Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 30, 2025
Hepatocellular
carcinoma
(HCC)
is
the
predominant
form
of
primary
liver
cancer
and
a
major
contributor
to
cancer-related
mortality
globally.
Central
its
pathogenesis
dysregulation
lipid
metabolism
in
hepatocytes,
leading
abnormal
accumulation.
Our
bioinformatics
analysis
has
identified
histone
acetyltransferase
complex
subunit
VPS72
as
being
associated
with
HCC,
yet
precise
molecular
mechanisms
through
which
contributes
hepatocarcinogenesis
remain
poorly
understood.
extensive
HCC
patient
cohorts
identifies
significant
proportion
copy
number
gains,
are
strongly
linked
adverse
prognostic
outcomes.
By
integrating
RNA-Seq,
ChIP-Seq,
ATAC-seq,
experimental
validation,
we
show
that
overexpression
activates
mTORC1
signaling,
subsequently
promoting
synthesis
driving
progression.
We
further
uncover
modulates
epigenetic
landscape
by
enhancing
DNA
methylation
at
ATF3
promoter,
resulting
repression
subsequent
activation
mTORC1.
This
study
elucidates
novel
regulatory
axis
links
dysregulated
progression,
highlighting
potential
metabolic
targets
for
therapeutic
intervention.
Language: Английский